Tiffany D. Ricketts

Tiffany D. Ricketts

Auto-generated profile, based on publicly available information

Tiffany D. Ricketts

Division of Hematology and Oncology, Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ADAdonis D’mello
Adonis D’mello
ARAshleigh Riegler
Ashleigh Riegler
EMEriel Martínez
Eriel Martínez
SBSarah M. Beno
Sarah M. Beno
TRTiffany D. Ricketts
Tiffany D. Ricketts
HTHervé Tettelin
Hervé Tettelin
Significance: We detail host–pathogen interaction gene-expression profiles of Streptococcus pneumoniae ( Spn ) and its infected host at disease relevant anatomical sites using mice as experimental models. We identify the shared and organ-specific transcriptomes of Spn , show that bacterial and host gene-expression profiles are highly distinct during asymptomatic colonization versus disease-causing infection, and demonstrate that Spn and host genes with high levels of expression contribute to pathogenesis or host defense, respectively, making them optimal targets for intervention.

13 February 2025 in Blood Advances
Verified
Journal Article
Open access
VKValeriya Kuznetsova
Valeriya Kuznetsova
VKVaidehi Krishnan
Vaidehi Krishnan
ACAmanda Costa
Amanda Costa
XRXi Ren
Xi Ren
TRTiffany D. Ricketts
Tiffany D. Ricketts
RWRobert Welner
Robert Welner
Natural killer (NK) cells play an integral role in immunosurveillance against myeloid malignancies, with their mature phenotype and abundance linked to prolonged treatment-free remission in chronic myeloid leukemia (CML). However, NK cell function is suppressed during the disease, and the orchestrators of this impairment are not fully understood. Using a chimeric BCR::ABL1+ CML mouse model, we characterized the impact of the leukemic microenvironment on NK cell function. We showed that NK cells have reduced counts, immature phenotype, poor cytotoxicity, and altered expression of activating and inhibitory receptors in CML mice, which revert to a steady state upon BCR::ABL1 inhibition. Single-cell RNA sequencing revealed an inflammatory cytokine response in CML-exposed NK cells, highlighted by the tumor necrosis factor α (TNFα)-induced gene signature, upregulation of TNFα receptor 2, and enrichment of suppressor of cytokine signaling family genes such as Cish, the critical NK cell checkpoint. Ex vivo exposure of healthy NK cells to leukemic soluble factors compromised target-specific NK cell degranulation, which was partially rescued by targeting Cish or TNFα. In alignment with these findings, NK cells from healthy donors displayed suppressed cytotoxicity when exposed to plasma from untreated patients with CML, with a partial restoration upon Cish or TNFα inhibition. Furthermore, NK cells from newly diagnosed patients with CML predestined for blast crisis showed an enrichment of the TNFα-induced proinflammatory gene signature identified in CML mice. These results suggest that targeting inflammatory signaling could enhance NK cell-based immunotherapies for CML.